Comparison of three enzyme-linked immunosorbent assays for detection of immunoglobulin g antibodies to tetanus toxoid with reference standards and the impact on clinical practice
Accurate determination of the concentrations of immunoglobulin G (IgG) antibody to tetanus toxoid is important in order to evaluate the immunogenicity of tetanus toxoid vaccines, determine immune competence in individual patients, and measure the prevalence of immunity in populations. The performance of three commercially available enzyme-linked immunosorbent assays (ELISAs) for IgG antibodies to tetanus toxoid were evaluated. Serially diluted NIBSC 76/589 and TE-3 human tetanus IgG immunoglobulin international reference standards were analyzed in quadruplicate using ELISAs manufactured by The Binding Site, Inc. (VaccZyme); Scimedx; and Euroimmun. In addition, IgG antibodies to tetanus toxoid were measured in 83 deidentified serum specimens using each manufacturer's ELISA. Each ELISA provided linear results when evaluated with the reference preparations. The Binding Site ELISA provided results that closely corresponded to the reference preparations (y=1.09x-0.08), whereas the Scimedx ELISA gave results that were consistently lower (y=0.21x-0.07) and the Euroimmun ELISA gave results that were consistently higher (y=1.5x+0.30) than the reference preparation concentrations. Using the recommended cutoff for each ELISA (\textless0.10 IU/ml), the overall agreement of all of the ELISA methods was 78\%. Three of eighty-three (3.6\%) human serum samples demonstrated inadequate immunity with all three assays. The Binding Site ELISA yielded nonprotective antibody concentrations in only these 3 samples, whereas 19 samples (22.9\%) according to the Scimedx ELISA and 6 samples (7.2\%) according to the Euroimmun ELISA demonstrated nonprotective concentrations. The performance characteristics of ELISAs for tetanus immunoglobulin titers were manufacturer dependent, and the differences translated into important disparities in reported results.
%0 Journal Article
%1 van_hoeven_comparison_2008
%A van Hoeven, Karen H
%A Dale, Connie
%A Foster, Phil
%A Body, Barbara
%D 2008
%J Clinical and Vaccine Immunology: CVI
%K Antibodies, Assay, Bacterial, G, Humans, Immunoglobulin Immunosorbent Reference Sensitivity Specificity, Standards, Tetanus Toxoid and {Enzyme-Linked}
%N 12
%P 1751--1754
%R 10.1128/CVI.00254-08
%T Comparison of three enzyme-linked immunosorbent assays for detection of immunoglobulin g antibodies to tetanus toxoid with reference standards and the impact on clinical practice
%U http://www.ncbi.nlm.nih.gov/pubmed/18845832
%V 15
%X Accurate determination of the concentrations of immunoglobulin G (IgG) antibody to tetanus toxoid is important in order to evaluate the immunogenicity of tetanus toxoid vaccines, determine immune competence in individual patients, and measure the prevalence of immunity in populations. The performance of three commercially available enzyme-linked immunosorbent assays (ELISAs) for IgG antibodies to tetanus toxoid were evaluated. Serially diluted NIBSC 76/589 and TE-3 human tetanus IgG immunoglobulin international reference standards were analyzed in quadruplicate using ELISAs manufactured by The Binding Site, Inc. (VaccZyme); Scimedx; and Euroimmun. In addition, IgG antibodies to tetanus toxoid were measured in 83 deidentified serum specimens using each manufacturer's ELISA. Each ELISA provided linear results when evaluated with the reference preparations. The Binding Site ELISA provided results that closely corresponded to the reference preparations (y=1.09x-0.08), whereas the Scimedx ELISA gave results that were consistently lower (y=0.21x-0.07) and the Euroimmun ELISA gave results that were consistently higher (y=1.5x+0.30) than the reference preparation concentrations. Using the recommended cutoff for each ELISA (\textless0.10 IU/ml), the overall agreement of all of the ELISA methods was 78\%. Three of eighty-three (3.6\%) human serum samples demonstrated inadequate immunity with all three assays. The Binding Site ELISA yielded nonprotective antibody concentrations in only these 3 samples, whereas 19 samples (22.9\%) according to the Scimedx ELISA and 6 samples (7.2\%) according to the Euroimmun ELISA demonstrated nonprotective concentrations. The performance characteristics of ELISAs for tetanus immunoglobulin titers were manufacturer dependent, and the differences translated into important disparities in reported results.
@article{van_hoeven_comparison_2008,
abstract = {Accurate determination of the concentrations of immunoglobulin G {(IgG)} antibody to tetanus toxoid is important in order to evaluate the immunogenicity of tetanus toxoid vaccines, determine immune competence in individual patients, and measure the prevalence of immunity in populations. The performance of three commercially available enzyme-linked immunosorbent assays {(ELISAs)} for {IgG} antibodies to tetanus toxoid were evaluated. Serially diluted {NIBSC} 76/589 and {TE-3} human tetanus {IgG} immunoglobulin international reference standards were analyzed in quadruplicate using {ELISAs} manufactured by The Binding Site, Inc. {(VaccZyme);} Scimedx; and Euroimmun. In addition, {IgG} antibodies to tetanus toxoid were measured in 83 deidentified serum specimens using each manufacturer's {ELISA.} Each {ELISA} provided linear results when evaluated with the reference preparations. The Binding Site {ELISA} provided results that closely corresponded to the reference preparations (y=1.09x-0.08), whereas the Scimedx {ELISA} gave results that were consistently lower (y=0.21x-0.07) and the Euroimmun {ELISA} gave results that were consistently higher (y=1.5x+0.30) than the reference preparation concentrations. Using the recommended cutoff for each {ELISA} ({\textless}0.10 {IU/ml),} the overall agreement of all of the {ELISA} methods was 78\%. Three of eighty-three (3.6\%) human serum samples demonstrated inadequate immunity with all three assays. The Binding Site {ELISA} yielded nonprotective antibody concentrations in only these 3 samples, whereas 19 samples (22.9\%) according to the Scimedx {ELISA} and 6 samples (7.2\%) according to the Euroimmun {ELISA} demonstrated nonprotective concentrations. The performance characteristics of {ELISAs} for tetanus immunoglobulin titers were manufacturer dependent, and the differences translated into important disparities in reported results.},
added-at = {2011-03-11T10:05:34.000+0100},
author = {van Hoeven, Karen H and Dale, Connie and Foster, Phil and Body, Barbara},
biburl = {https://www.bibsonomy.org/bibtex/286507fd74dc9c2f9e344b507967b6e87/jelias},
doi = {10.1128/CVI.00254-08},
interhash = {3af4a8b100206009a2006f793f5466b3},
intrahash = {86507fd74dc9c2f9e344b507967b6e87},
issn = {{1556-679X}},
journal = {Clinical and Vaccine Immunology: {CVI}},
keywords = {Antibodies, Assay, Bacterial, G, Humans, Immunoglobulin Immunosorbent Reference Sensitivity Specificity, Standards, Tetanus Toxoid and {Enzyme-Linked}},
month = dec,
note = {{PMID:} 18845832},
number = 12,
pages = {1751--1754},
timestamp = {2011-03-11T10:06:33.000+0100},
title = {Comparison of three enzyme-linked immunosorbent assays for detection of immunoglobulin g antibodies to tetanus toxoid with reference standards and the impact on clinical practice},
url = {http://www.ncbi.nlm.nih.gov/pubmed/18845832},
volume = 15,
year = 2008
}